The GCC catheter market is projected to grow from USD 579.83 million in 2024 to USD 1.28 billion by 2033, with a CAGR of 9.21 ...
WASHINGTON, DC—In PEERLESS, the first randomized controlled trial pitting two different interventional strategies against each other in pulmonary embolism (PE), patients with acute intermediate-risk ...
David Jenkins, CEO of Catheter Precision, commented, “We are pleased that additional intellectual property is being confirmed through the issuance of patents by the USPTO. This creates value for our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback